Zymergen Inc. Common Stock
ZY was delisted on the 18th of October, 2022.
81 hedge funds and large institutions have $71.4M invested in Zymergen Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 28 closing their positions.
38% more call options, than puts
Call options by funds: $215K | Put options by funds: $156K
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
11% less funds holding
Funds holding: 91 → 81 (-10)
29% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 28
40% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 25
63% less capital invested
Capital invested by funds: $193M → $71.4M (-$121M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Plustick Management
Charlottesville,
Virginia
|
+$1.17M |
| 2 |
Millennium Management
New York
|
+$1.15M |
| 3 |
Morgan Stanley
New York
|
+$1.12M |
| 4 |
E
Ergoteles
New York
|
+$601K |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$533K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$6.32M |
| 2 |
JP Morgan Chase
New York
|
-$3.1M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
-$2.13M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.84M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.36M |
ZY Hedge Fund Activity: Q2 2022 in Review
81 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Zymergen Inc. Common Stock (ZY) for Q2 2022, worth a combined $71.4M — down 63% from $193M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of ZY and 20 opened new positions — a net loss of 8 holders — while 25 trimmed existing stakes and 15 added.
The largest buyer was Plustick Management, opening a new position worth an estimated $1.17M. The largest seller was BlackRock, cutting an estimated $6.32M.
- 81 institutional investors held Zymergen Inc. Common Stock (ZY) as of Q2 2022, down from 91 in Q1 2022.
- Funds reported $71.4M of Zymergen Inc. Common Stock stock for Q2 2022, down 63% quarter-over-quarter.
- 20 funds opened new Zymergen Inc. Common Stock positions in Q2 2022 and 28 closed out, a net change of -8 holders.
- The largest Zymergen Inc. Common Stock buyer in Q2 2022 was Plustick Management, an estimated $1.17M added.
- The largest Zymergen Inc. Common Stock seller in Q2 2022 was BlackRock, an estimated $6.32M sold.
Based on aggregated 13F filings for Q2 2022.